Clare Davenport
 
                            Institute of Applied Health Research                                                        
University of Brimigham
                                                        United Kingdom
                        
Biography
Clare Davenport is a specialist public health practitioner coming to the end of a doctoral research programme concerned with the development of methods of conducting and presenting the results of systematic reviews of test accuracy that meet the needs of decision makers. Clare’s main area of expertise is systematic review methodology. In addition to systematic reviews and meta-analysis of diagnostic tests she has experience of undertaking reviews and health technology assessments in diverse topic areas including health impact assessment, pharmacological interventions, complex behavioural interventions, population level interventions and qualitative research, on the basis of successful grant applications to the National Institute for Health and Clinical Excellence, the Centre for Public Health Excellence and NETSCC HTA . Clare contributes to the delivery of undergraduate and post-graduate teaching, as well as training for the local NHS community, drawing on her research and broader public health expertise.
Research Interest
Systematic review methodology; in particular systematic reviews of test accuracy, systematic reviews of complex interventions, systematic reviews of qualitative research. Mixed methods synthesis Diagnostic decision making
Publications
- 
                            
Pennant M, Davenport C, Bayliss S, Greenheld W, Marshall T, Hyde C. Community programmes for the prevention of cardiovascular disease: a systematic review. 2010. American Journal of Epidemiology;172(5):501-516
 - 
                            
Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, Eisinga A, Andronis A, Arvanitis T, Hyde C. 2010. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. Health Technol Assess; 14 (5): 1-103.